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Background: In this report we have explored the genomic and microbiological basis for a sustained increase in
bloodstream infections at a major Australian hospital caused by Enterococcus faecium multi-locus sequence type
(ST) 203, an outbreak strain that has largely replaced a predecessor ST17 sequence type.
Results: To establish a ST203 reference sequence we fully assembled and annotated the genome of Aus0085, a
2009 vancomycin-resistant Enterococcus faecium (VREfm) bloodstream isolate, and the first example of a completed
ST203 genome. Aus0085 has a 3.2 Mb genome, comprising a 2.9 Mb circular chromosome and six circular plasmids
(2 kb–130 kb). Twelve percent of the 3222 coding sequences (CDS) in Aus0085 are not present in ST17 E. faecium
Aus0004 and ST18 E. faecium TX16. Extending this comparison to an additional 12 ST17 and 14 ST203 E. faecium
hospital isolate genomes revealed only six genomic regions spanning 41 kb that were present in all ST203 and
absent from all ST17 genomes. The 40 CDS have predicted functions that include ion transport, riboflavin
metabolism and two phosphotransferase systems. Comparison of the vancomycin resistance-conferring Tn1549
transposon between Aus0004 and Aus0085 revealed differences in transposon length and insertion site, and van
locus sequence variation that correlated with a higher vancomycin MIC in Aus0085. Additional phenotype
comparisons between ST17 and ST203 isolates showed that while there were no differences in biofilm-formation
and killing of Galleria mellonella, ST203 isolates grew significantly faster and out-competed ST17 isolates in growth
assays.
Conclusions: Here we have fully assembled and annotated the first ST203 genome, and then characterized the
genomic differences between ST17 and ST203 E. faecium. We also show that ST203 E. faecium are faster growing
and can out-compete ST17 E. faecium. While a causal genetic basis for these phenotype differences is not provided
here, this study revealed conserved genetic differences between the two clones, differences that can now be tested
to explain the molecular basis for the success and emergence of ST203 E. faecium.
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Enterococci are part of the human gastrointestinal tract
microbiota but some species within the genus are also
significant opportunistic nosocomial pathogens [1].
Enterococcal infections can be difficult to treat because of
their intrinsic and acquired resistance to many classes of
antibiotics, including what are often considered last-line
agents such as vancomycin and daptomycin [2,3]. The
difficulties associated with treatment, coupled with
the risk of cross transmission to other patients, make
enterococcal infections a significant infection control
issue in hospitals [1].
Enterococci that are resistant to vancomycin are
collectively referred to as vancomycin-resistant enterococci
(VRE) [4,5]. Vancomycin resistance is conferred by the
presence of one of nine different gene clusters, although
the majority of VRE strains possess either the vanA or vanB
operon [6-8]. Enterococcus faecium and Enterococcus
faecalis are the two enterococci most frequently causing
human infections, however vancomycin resistance has
become increasingly common predominately in E. faecium,
in the past two decades [9,10]. The first reported cases of
VRE occurred in Europe and the UK in the 1980s and VRE
has since been reported in hospitals worldwide [11,12]. In
Australia, the first known case of VRE was reported at the
Austin Hospital in 1994 [13]. VRE has since emerged
Australia-wide and a number of Australian hospitals have
experienced VRE outbreaks, predominantly involving
colonization in the clinical environment [14]. In contrast to
the United States where vanA-type resistance predomi-
nates, vanB-type vancomycin resistant E. faecium are the
most important cause of VRE infections in Australia [15].
Molecular epidemiology of E. faecium has been based
primarily on pulsed field gel electrophoresis (PFGE) and
multi-locus sequence typing (MLST) [16,17]. MLST has
revealed the emergence of related lineages called clonal
complex 17 (CC17), which comprise strains associated
with hospital infections across at least five continents [18].
Many of these hospital strains have acquired resistance to
ampicillin and quinolones, and their genomes contain a
high number of mobile genetic elements that distinguish
them from community-acquired and non-pathogenic
strains [18-20].
We have previously reported on a significant increase
in cases of E. faecium bacteraemia at a major Australian
Hospital. MLST of the E. faecium isolates collected from
bacteraemic patients over a 12-year period revealed a
replacement of CC17 sequence type 17 (ST17) strains, with
emergent CC17 ST203 isolates [14]. A survey evaluating
the incidence of VRE and vancomycin-susceptible
enterococci (VSE) in Australia from 2005 to 2010,
conducted by the Australian Group on Antimicrobial
Resistance (AGAR) in collaboration with participating
microbiology labs, showed a marked increase in VRErates throughout Australia. Reflecting the very same trends
observed at Austin Health, the majority of these Australian
VRE strains not only possessed the vanB gene but were
also ST203 [21]. In our initial study we compared partially
assembled genome sequences for representative ST17
(Aus0004) and ST203 (Aus0085) VRE isolates and showed
500 kb of unique DNA differentiating the two [14]. We
also recently established and analysed the complete gen-
ome sequence of E. faecium ST17 Aus0004 as a basis for a
more thorough genome comparison [22].
In this current study, genome and phenotype compari-
sons were performed to explore in more detail the differ-
ences between 13 ST17 and 15 ST203 E. faecium isolates
to help explain the emergence of ST203 and its success as
an opportunistic hospital pathogen. We fully assembled
and annotated the genome of E. faecium ST203 Aus0085,
the first complete ST203 reference sequence, and com-
pared it with the recently fully assembled and annotated
genomes of ST17 Aus0004 and ST18 isolate TX16 [22,23].
Growth rates and biofilm formation were also mea-
sured for a collection of ST17 and ST203 isolates,
and virulence was assessed in the Greater Wax Moth
(Galleria mellonella) invertebrate model.
Results
Enterococcus faecium Aus00085 genome summary
The genome of E. faecium Aus0085 is comprised of a
single circular chromosome (2,994,661 bp) with a GC
content of 38.2%, 2,922 protein-coding DNA sequences
(CDS), 75 tRNA genes, and 6 rRNA operons. Compari-
sons of an in silico NcoI map of the fully-assembled
Aus0085 chromosome sequence against the Aus0085
NcoI optical map confirmed the accuracy of the chromo-
some assembly (Figure 1A). Aus0085 also harbors six cir-
cular plasmids, Aus0085_p1, Aus0085_p2, Aus0085_p3,
Aus0085_p4, Aus0085_p5 and Aus0085_p6, with lengths
of 130,716 bp, 67,314 bp, 31,004 bp, 9,319 bp, 4,072 bp,
2,189 bp respectively.
Comparative genomics of Aus0085 E. faecium
The chromosome features for ST203 E. faecium Aus0085
were compared with ST17 E. faecium Aus0004 and
another recently closed E. faecium genome, TX16 (Table 1).
Chromosome alignments indicated significant conserva-
tion of genome architecture between the three isolates.
The large chromosome inversion seen in Aus0004 is not
present in Aus0085 and TX16 (Figure 1B). DNA compari-
sons and ortholog cluster analysis showed that E. faecium
Aus0085 possesses at least 8 chromosomal segments span-
ning approximately 224 kb that are not present in both
Aus0004 and TX16, and an additional four regions span-
ning 133 kb that are absent in Aus0004 but present in
TX16. These Aus0085 ‘specific’ regions include four dis-
tinct prophage, and loci involved in metabolic functions
Figure 1 Comparative analysis of the complete genome sequence of E. faecium Aus0085. (A) Alignment of E. faecium Aus0085 NcoI
optical map with an in silico-generated NcoI map of the final chromosome assembly, demonstrating the accuracy of the assembly. (B) Alignment
of the chromosomes from E. faecium strains Aus0004, Aus0085 and TX16, generated using the Artemis Comparison Tool. The gray bands located
at the top, middle and bottom represent the forward and reverse DNA strands for the chromosome sequences belonging to Aus0004, Aus0085
and TX16 respectively. The red lines correspond to regions of similarity between two chromosomes. The blue lines correspond to regions of
similarity between two chromosomes in differing orientations. White regions are those that are unique to one strain and absent in the other.
(C) Circular map of ST203 Aus0085 showing DNA-DNA comparisons against ST17 Aus0004 and ST18 TX16. Track identification, moving outwards,
is as follows: G + C content, GC skew, E. faecium Aus0085, E. faecium Aus0004, E. faecium TX16, and finally the location of prophage regions,
Tn1549 transposon and the esp-pathogenicity island.
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Table 1 Genome comparisons between E. faecium strains Aus0004 (ST17), Aus0085 (ST203) and TX16
ST17 Aus0004 ST203 Aus0085 ST18 TX16
Chromosome size (G + C%) 2,955,294 bp (38.4%) 2,994,661 bp (38.2%) 2,698,137 bp (38.15%)
Plasmids (size, G + C%) Aus0004_p1 (56,520 bp, 35.4%) Aus0085_p1 (130,716 bp, 34.9%) pDO1 (36,262 bp, 36.51%)
Aus0004_p2 (4,119 bp, 36.8%) Aus0085_p2 (67,314 bp, 35.2%) pDO2 (66,247 bp, 34.38%)
Aus0004_p3 (3,847 bp, 39.0%) Aus0085_p3 (31,004 bp, 34.6%) pDO3 (251,926 bp, 35.97%)
Aus0085_p4 (9,319 bp, 30.9%)
Aus0085_p5 (4,072 bp, 36.2%)
Aus0085_p6 (2,189 bp, 38.9%)
CDS 2,932 3,222 3,114
rRNA operons 6 6 6
tRNA 47 75 64
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complete list of Aus0085 genes not present in Aus0004 or
TX16 is provided see (Additional file 1: Table S1).
To refine this comparative analysis, whole genome
sequence reads obtained from an additional 12 ST17 and
14 ST203 previously described hospital isolates were
mapped to the Aus0085 chromosome. Seven distinct
regions of difference were identified, spanning 41 kb and
40 genes found in all 15 ST203 isolates but absent from
the ST17 collection (Figure 2A). The majority of these
genes encoded proteins with functions related to metabol-
ism including riboflavin biosynthesis (Ef_aus0085_01495),
gene regulation (Ef_aus0085_00243, Ef_aus0085_01493,
Ef_aus0085_02507, Ef_aus0085_02509), metal ion trans-
port (Ef_aus0085_00246) and phosphotransferase systems
(Ef_aus0085_02768, Ef_aus0085_02779) (Figure 2A and
Additional file 2: Table S2).
Read-mapping also permitted delineation of a core
genome, revealing 2,217,189 bases, (Aus0085 genome:
75% core and 25 % accessory) that were present in all 28 E.
faecium genomes. Pairwise comparisons of the Aus0085
core genome sequence with the core genomes of the other
isolates uncovered 9865 variable nucleotide positions
(including substitutions and indels). A distance matrix was
prepared and a robust phylogeny was inferred by both split
decomposition analysis and neighbor-joining methods
that highlighted the substantial nucleotide differences
between ST203 and ST17 isolates (Figure 2B). A reticu-
lated phylogeny was observed by split decomposition, in-
dicating likely recombination among this collection of E.
faecium (data not shown). These substantial clone-specific
differences were then confirmed by independent in silico
analysis. De novo assembly with gene and protein
prediction of the 26 E. faecium genomes (Table 2),
followed by ortholog clustering that also included
Aus0085 and Aus0004 based on MLST category, con-
firmed the same 40 ST203-specific genes as identified
by read-mapping (Figure 2C, Additional file 2: Table S2).The two MLST groups shared 1247 genes, while there
were 31 genes specific to the ST17 isolates (Figure 2C,
Additional file 2: Table S2).
The Aus0085 genome is largely comprised of mobile
genetic elements
Like Aus0004 and TX16, a large proportion of the genome
for Aus0085 is comprised of mobile genetic elements. A
total of 91 insertion sequence elements (ISEs), representing
twenty different types of ISEs, were identified. The copy
numbers of the ISEs varied from 1 to 24. The most
frequently occurring ISE differed between Aus0004
(ISEf1, 13 copies) and Aus0085 (ISEfa5, 24 copies).
Four distinct prophage were identified in Aus0085
including, phiEnfa004 (782514–827419), phiEnfa005
(876860–925798), phiEnfa006 (2208334–2256786) and
phiEnfa007 (2439241–2497696). The Aus0085 prophage
are distinct to the prophage regions present in Aus0004
and TX16, although as demonstrated in Figure 1C, many of
the CDS that make up phiEnfa004 also appear in the other
two genomes, which suggests this prophage is reasonably
conserved. Interestingly, the two CRISPR-associated pro-
teins present in the prophages phiEnfa001 and phiEnfa002
in Aus0004 are not present in Aus0085, and no other
CRISPR loci were detected in Aus0085.
The Tn1549-like vanB-containing transposon in Aus0085
is distinct from Aus0004
A single copy of a Tn1549-like transposon, encoding
vanB-type vancomycin resistance, was present in the
Aus0085 chromosome, inserted within a signal peptidase
I gene (EFAU085_00682) between nucleotide positions
723825–781312, which is different from the insertion
site in Aus0004 (Figure 1C). Comparisons of Tn1549
between Aus0004 and Aus0085 revealed a conserved 30
kb core (Figure 3A). However, Tn1549 in Aus0085 is
significantly larger, containing an additional 23.7 kb with
20 CDS that appear to encode another conjugative
Figure 2 Comparative multi-isolate genome analysis. (A) Read-mapping outputs from whole genome sequencing of an additional 12 ST17
and 14 ST203 isolates against the completely-assembled chromosome sequence for Aus0085. The six genomic regions and integrase gene
present in all ST203 isolates and absent in all ST17 isolates are highlighted and numbered. The remaining unnumbered highlighted areas
correspond to regions in the Aus0085 genome that are not present in Aus0004. (B) SNP-based neighbor-joining tree, showing the relationship
between the ST17 and ST203 isolates. (C) Venn diagram depicting the shared genes present in all the ST17 and ST203 strains and the specific
genes that were present in all ST17 and absent from all ST203 isolates, and vice-versa.
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chromosomal location, it can take 4–6 bp of flanking
sequence from the donor DNA that is then incorporated
in the recipient at the site of insertion [24]. Different
donor sequences (also called coupling sequences) were
observed between Aus0004 and Aus00085, which to-
gether with the different form of Tn1549 indicate a dif-
ferent source of this transposon for each isolate
(Figure 3B). The van locus in Aus0085 was differentiated
from the Aus0004 version by 2 non-conservative amino
acid substitutions that may impact function located
within the histidine kinase domain of VanS (E251G) and
the N-terminal substrate-binding domain of VanB (C101F).
Interestingly, the vancomycin minimal inhibitory concen-
tration (MIC) for Aus0004 was 12 mg/L compared with
256 mg/L for Aus0085.Additional plasmids in Aus0085 contribute to the
Aus0085-specific genome
Aus0085 harbors six plasmids, compared to three plas-
mids in Aus0004. The increased number of plasmids
adds an additional 180 kb to the Aus0085 genome, with
plasmid sizes ranging from 2.2 kb to 130.7 kb. Table 4 con-
tains a summary of the predicted functions of plasmid
CDS. Comparisons of the plasmid sequences in Aus0085
against the genome sequences from other enterococci show
that the majority of sequence and CDS in the Aus0085
plasmids are also present in plasmids from E. faecium
(including Aus0004), E. faecalis and other enterococcal
species as well as other species from other genera such as
Staphylococcus and Streptococcus. Plasmid comparisons
between Aus0004 and Aus0085 reveal that Aus0085_p2 is
highly related (99% sequence identity) to Aus0004_p1, a
Table 2 E. faecium strains used in this study
Strain Year of isolation MLST sequence type van type
Aus0004 1998 ST17 vanB
Aus0006 1999 ST17 -*
Aus0007 1999 ST17 -
Aus0012 2000 ST17 vanB
Aus0100 2000 ST17 -
Aus0015 2002 ST17 -
Aus0098 2003 ST17 -
Aus0019 2004 ST17 -
Aus0021 2004 ST17 vanB
Aus0026 2005 ST17 -
Aus0029 2005 ST203 -
Aus0040 2006 ST203 -
Aus0041 2006 ST203 -
Aus0043 2006 ST203 -
Aus0045 2007 ST203 vanB
Aus0048 2007 ST203 vanB
Aus0053 2007 ST203 -
Aus0055 2007 ST203 vanB
Aus0070 2008 ST203 vanB
Aus0078 2008 ST203 -
Aus0080 2008 ST17 -
Aus0084 2009 ST17 vanB
Aus0085 2009 ST203 vanB
Aus0087 2009 ST203 vanB
Aus0090 2009 ST203 vanB
Aus0091 2009 ST203 vanB
Aus0096 2009 ST203 vanB
Aus0094 2009 ST17 -
*indicates strains that are vancomycin-susceptible isolates, which therefore do
not possess the van operon.
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is 10.8 kb longer. Additionally, Aus0085_p5 is closely
related to Aus0004_p3. The smallest plasmid Aus0085_p6
(2.2 kb), which has no other CDS other than that encoding
the replication initiation protein, possesses three regions
(nucleotide positions 1–938, 1182–1608 and 1982–2189)
that share significant sequence identity (80%, 92% and
85% respectively) to the cryptic plasmid pRI1 [25].
A total of 99 CDS, which represents one-third of the
CDS that makes up the 245 kb plasmid sequence in
Aus0085, are not present in Aus0004, and some of these
genes are candidates to explain the growth and anti-
microbial susceptibility differences between ST17 and
ST203 isolates. With the exception of EFAU085_p2057,
which encodes a hypothetical protein that is found only
in Aus0085, all the other Aus0085 CDS that do notappear in Aus0004 are present in the genomes belonging
to other E. faecium isolates or other enterococcal species.
Among the plasmid CDS that have been assigned a func-
tion, several encode important features that enhance the
survival of Aus0085. Notably, the aadE-sat4-aphA gene
cluster, reported in a number of multidrug-resistant E.
faecium and E. faecalis strains, is present on plasmid
Aus0085_p3. The genes in the aadE-sat4-aphA cluster
confer resistance to three different antibiotics, strepto-
mycin, streptothricin and kanamycin, respectively [26].
However, sat4 is disrupted by an ISE (EFAU085_p3014)
and is therefore unlikely to be functional. The aadE and
aphA genes are intact. Streptomycin MICs differed as
predicted between Aus0004 and Aus0085, with values of
48 mg/L and 1024 mg/L respectively.
Other Aus0085 plasmid CDS that encode important
features that are absent in Aus0004 include a PTS-lactose
uptake system (lacG, lacE, lacF, lacD2, lacC, lacB, lacA) on
Aus0085_p1, a bacterial extracellular solute-binding
protein on Aus0085_p1 and additional toxin-antitoxin
systems on plasmids Aus0085_p1 and Aus0085_p3.
Interestingly, Aus0085_p1 possesses a citrate lyase
complex (oadHDB-citCDEFX-oadA-citMG), which has
been previously described in various Firmicutes including E.
faecium and E. faecalis [27,28]. However, this locus may be
non-functional as citC and citG are predicted pseudogenes.
Additionally, the other auxiliary genes required for
producing an active citrate lyase appear to be absent
from Aus0085_p1.
CDS associated with virulence
The same putative enterococcal virulence factors
identified in Aus0004 were also present in Aus0085.
While the sequences of the genes encoding hemoly-
sin (EFAU085_01000) and collagen-binding adhesin
(acm; EFAU085_02356) were nearly identical to the
corresponding genes in Aus0004 (99-100% identity).
The enterococcal surface protein (esp) encodes a
1733 aa protein with a likely role in colonization
[29,30]. The Aus0085 esp gene (EFAU085_2821) has
an additional 264 bp representing an extra copy of
one of its 3′ tandem repeats compared to the Aus0004
ortholog.
Bacteriocins are small protein pore-forming toxins
produced by certain bacteria that can prevent the growth
of closely related strains [31,32]. We therefore compared
the bacteriocin gene content of Aus0085 with Aus0004
to see if additional bacterioicin-like genes might explain
the emergence of Aus0085. However genome comparisons
showed no novel bacteriocins in Aus0085 and both isolates
shared the same complement of three bacteriocin genes
(>99% nt identity between each clone), although their
genome location varied. For example a gene encoding a
lactococcin 972-like protein is present on Aus0085 plasmid
Figure 3 Analysis of Tn1549. (A) Chromosomal location and alignment of Tn1549 from E. faecium isolates Aus0004 (nucleotide positions
2835430–2869240) and Aus0085 (nucleotide positions 723825–781312, reverse orientation). Compared to Tn1549 in Aus0004, the element in
E. faecium Aus0085 is 23.7 kb longer. White regions correspond to the unique 23.7 kb sequence. The red regions correspond to matches between
the two transposons. (B) Transposon insertion site comparisons showing the left-hand side and right-hand side flanking regions and donor
(coupling) sequences.
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(EFAU004_00292).
E. faecium ST203 isolates grow more quickly than ST17
To determine whether there were any differences in growth
rates between different isolates, which might be linked to
the additional metabolic genes or the lactose metabolism
pathway identified in the genome for ST203-representative
strain Aus0085, we conducted growth curve experimentsto compare doubling times between the ST17 and ST203
strains. Exponential phase doubling times were calculated
and a significant difference (p = 0.0304) was observed
between ST17 (average: 55.186 min, SD: 8.216 min)
and ST203 isolates (average: 48.136 min, SD: 7.611 min)
(Figure 4). The doubling times for the two sequenced
strains were not different; Aus0004 possessed an average
doubling time of 66.1 minutes while average doubling
time for Aus008 was 65.3 minutes.







EFAU085_00684 724423 to 725631 IS110, transposase
EFAU085_00689 728728 to 730545 HNH endonuclease
domain protein
EFAU085_00692 732291 to 732638 Hypothetical protein
EFAU085_00693 732653 to 732934 Hypothetical protein
EFAU085_00694 733193 to 733975 RNase II stability modulator
EFAU085_00695 734148 to 735866 Na+/Pi- cotransporter
EFAU085_00696 735868 to 736722 Phosphate binding protein
EFAU085_00697 736688 to 736801 Hypothetical protein
EFAU085_00698 737419 to 737718 Hypothetical protein
EFAU085_00699 737742 to 738152 Single strand binding protein
EFAU085_00700 738299 to 738505 Putative transcriptional regulator
EFAU085_00701 738852 to 739373 TDP-fucosamine acetyltransferase
EFAU085_00702 739431 to 739856 Acetyltransferase, GNAT family
EFAU085_00703 740299 to 740481 Hypothetical protein
EFAU085_00704 740594 to 742105 Hypothetical protein
EFAU085_00705 742428 to 742652 Hypothetical protein
EFAU085_00706 742645 to 743211 Hypothetical protein
EFAU085_00707 743199 to 743429 Hypothetical protein
EFAU085_00708 743630 to 743995 Hypothetical protein
EFAU085_00709 743995 to 745722 Conjugal transfer relaxase TraA
EFAU085_00710 745761 to 747668 Hypothetical protein
EFAU085_00711 747933 to 748049 Hypothetical protein
EFAU085_00712 748353 to 748535 Hypothetical protein
EFAU085_00713 748562 to 750259 Resolvase family site-specific
recombinase
EFAU085_00737 776918 to 777724 ISEnfa3, transposase
EFAU085_00738 777721 to 728257 ISEnfa3, transposase
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ST17
We next took advantage of the high-level gentamicin
resistance of Aus0085 and Aus0090 and performed co-
culture experiments to assess whether these representa-
tive ST203 isolates could outcompete ST17 isolates. As
indicated by the relative competitive fitness index (RCFI)
(Figure 5), both ST203 isolates out-competed the ST17
isolates, Aus0004 and Aus0021, by approximately the
same factor. Statistical analysis showed all comparisons
were significantly higher than the threshold RCFI value
of 1. Aus0004, Aus0021 and Aus0085 possessed similar
doubling times of 66.068, 64.282 and 65.341 minutes
respectively. However, compared to the other strains,
Aus0004 took, on average, two hours longer to reach
stationary phase, and Aus0090 had a significantly faster
doubling time of 52.942 minutes.Biofilm formation is not an E. faecium clone-specific trait
The ability of E. faecium to form biofilms is thought to be
an important phenotype with respect to virulence traits
such as colonization, environmental persistence and anti-
biotic resistance [33-35]. We therefore performed biofilm
assays to determine whether a difference in biofilm forma-
tion abilities distinguished the two ST clones. Three E.
faecium ST17 strains Aus0006, Aus0019 and Aus0094
showed enhanced biofilm-forming capacity compared to
the other isolates (p < 0.05) but no relationship with
sequence type was observed (Figure 6).Virulence is a heterogeneous phenotype in both the ST17
and ST203 strains
We examined survival rates of G. mellonella larvae after in-
oculation with ST17 and ST203 E. faecium. The Kaplan
Meier plots were analysed to compare virulence between
isolates see (Additional file 3: Figure S1 and Additional file
4: Figure S2 for the individual Kaplan Meier survival plots
generated for each of the ST17 and ST203 isolates, respect-
ively). Based on observations made during the experiments,
isolates were considered virulent if all larvae within a group
died within three days of inoculation. Virulence varied
independent of sequence type (Figure 7). However, exclud-
ing Aus0087, which exhibited small colony variant morph-
ology, the ST203 strains isolated from 2009 onwards, killed
G. mellonella larvae within three days. Larvae inoculated
with small colony variant strains Aus0041, Aus0078 and
Aus0087 exhibited increased survival rates. The number of
bacteria present in the larvae at the time of death was also
quantified, with values ranging from 2.2 × 106 CFU/ml to
4.25 × 108 CFU/ml. Substantial variations were observed in
CFU, even in larvae that had been inoculated with
the same isolate, suggesting that differences in growth
between different sequence types does not explain the
rate at which the larvae are killed.Discussion
Nosocomial outbreaks of E. faecium are now dominated
by ST203 in Australia, and this ST has also been respon-
sible for nosocomial outbreaks in Germany and China
[36,37]. However, surprisingly little is known about this
group of clones or why it emerged almost simultaneously
in several hospitals and Australian states. Additionally, the
apparent shift from ST17 E. faecium to ST203 observed at
the Austin Hospital is reflected in a previous study that
examined the population structure of E. faecium. Hospital
isolates can be categorized into two groups (BAP2-1 and
BAP3-3) [38], with ST17 isolates belonging to BAP3-3
and ST203 isolates belonging to BAP2-1. These observa-
tions correlate with the trends observed at the Austin
Hospital and in hospitals around Australia, where strains
belonging to BAP3-3 dominated from 1990 to 2004, and
Table 4 Description of plasmids present in E. faecium strain Aus0085
Aus0085_p1 Aus0085_p2 Aus0085_p3 Aus0085_p4 Aus0085_p5 Aus0085_p6
Length 130,716 bp 67,314 bp 31,004 bp 9,319 bp 4,072 bp 2,189 bp
GC content 34.9% 35.2% 34.6% 30.9% 36.2% 38.9%
Rep family 2 17 2 Unique 14 14
No. of CDS 162 78 42 12 5 1















a rep protein, similar
to cryptic plasmid pRI1
aphA, sat4, aadE aminoglycoside





*F.O.I features of interest.
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onwards [14].
In this report, we have fully assembled and annotated
the genome of strain Aus0085. To our knowledge, this is
the first complete ST203 E. faecium genome sequence.
Comparisons with the only two other complete E.
faecium genomes, ST17 Aus0004 and ST18 TX16, were
performed to understand the genetic basis behind the
emergence and increase in ST203 VRE. Comparative
analysis revealed 502 kb of sequence present only in
Aus0085. These regions of difference spanned eight
chromosomal segments in Aus0085 (including four
distinct prophage) and four of the six plasmids harbored
by this isolate. Genome comparisons were extended to a
collection of ST17 and ST203 isolates and this reduced
the amount of ST203 ‘unique’ DNA to six chromosome
regions. Inferred functions from genes within these regions
suggest additional metabolic capabilities for the ST203
strains, particularly in carbohydrate utilization and metal
ion transport. Additional ST203-unique metabolic genes
include a riboflavin biosynthesis gene, dihydrofolate reduc-
tase and a fructose phosphotransferase system (PTS). PTS
are numerous in both gram-positive and negative bacteria,
and facilitate the transport, uptake and metabolism of
carbohydrates. A recent functional study showed that
deletion of E. faecium ptsD, which encodes a sugar-specific
membrane-associated EIID subunit of a PTS gene cluster
common to hospital isolates and absent in commensal
isolates, compromises the ability of E. faecium to colonise
the intestinal tract of mice under antibiotic treatment [39].
The results from this study and our observations here,
showing two putative PTS loci present in all ST203 but
absent from ST17 (Figure 2A), underscore the likely
important contributions of PTS systems (loci beginning at
Ef_aus0085_02768 and Ef_aus0085_02778), as well as other
metabolic functions, in defining the success of a strain
within a host and possibly the clinical environment.
Approximately 24% of the Aus0085-specific genes
(relative to Aus0004 and TX16) are found on the sixplasmids, highlighting the importance of these elements
in shaping the Aus0085 genome and the potential for
their transmission to other clinical E. faecium isolates.
Aus0085_p1 possesses genes with predicted lactose func-
tions that might allow for utilization of alternative carbohy-
drate sources. Enterococci in humans and other animals
colonize the gastrointestinal tract and consequently, they
compete with the gut microbiota for nutrients and
resources [1,40,41]. The presence of additional metab-
olism genes might therefore confer a survival and
growth advantage to ST203 in this environment. A
functional genomic study recently conducted investigating
carbohydrate metabolism in Streptococcus pneumoniae
revealed a 20-minute increase in doubling time in a lactose
PTS system mutant, suggesting that the additional lactose
utilization pathway in Aus0085 might similarly promote
the growth of ST203 [42]. Plasmid Aus0085_p3 possesses
an intact version of the aadE and aphA genes, which con-
fer resistance to streptomycin and kanamycin respectively.
Streptomycin susceptibility testing revealed a 20-fold
increase in the MIC of Aus0085 (1024 mg/L) compared to
Aus0004 (48 mg/L). The aphA kanamycin resistance gene
also confers resistance against gentamicin, which likely
explains the high-level gentamicin resistance observed
in Aus0085. Clinical isolates that exhibit high levels
of resistance against gentamicin are often treated using
streptomycin. Resistance against streptomycin in Aus0085,
probably conferred by aadE, is therefore a concern.
The genome comparisons also revealed significant
insights into the acquisition of the vancomycin resistance-
conferring transposon in the representative genomes.
Several transposons that are responsible for mediating
vanB-type resistance against vancomycin have previously
been described in enterococci: Tn1547, Tn1549 and
Tn5382. The 27 kb Tn5382 shares high sequence
homology to the 34 kb Tn1549 [43-45]. Previous studies
investigating the acquisition of vancomycin resistance
have provided some clues to the sources and mode of
transposon transmission, but there remains much to be
Figure 5 Relative competitive fitness of ST203 isolates Aus0085
and Aus0090 compared with ST17 isolates Aus0004 or
Aus0021. Grown in the presence of ST17 strains, all ST203 strains
outcompeted the ST17 strains in mixed cultures over 24 hours,
possessing a competitive relative fitness index value significantly
greater than 1.
Figure 4 Doubling times calculated from the growth curves of
E. faecium strains. The doubling times, in minutes, from early- to
late- exponential phase were determined for each of the E. faecium
strains. The values were plotted according to ST. The ST203 strains
appear to grow at a faster rate than the ST17 strains and statistical
analysis performed using the two-tailed Mann Whitney test
demonstrated that the difference was statistically significant
(p = 0.0304).
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http://www.biomedcentral.com/1471-2164/14/595determined [46-48]. While vancomycin resistance in both
Aus0004 and Aus0085 is conferred by the van operon
associated with a Tn1549-like conjugative transposon,
thorough transposon comparisons revealed substantial
differences between the transposon length, sequence and
site of insertion. The additional genes with a possible role
in conjugation may consequently affect transposon trans-
mission and spread. These variations show that Aus0004
and Aus0085 acquired their transposons from different
donors. Non-synonymous nucleotide changes within the
van locus coincide with the extent of vancomycin resist-
ance in Aus0085, with antimicrobial susceptibility testing
showing a 20-fold increase in the vancomycin MIC for
Aus0085 compared to Aus0004. The E251G substitution
within the histidine kinase domain of VanS and the C101Fchange within the N-terminal substrate-binding domain
of VanB are both candidates for further exploration to test
their role in the increased resistance to vancomycin
displayed by Aus0085.
The differences between the transposons in the ST17
and ST203 isolates not only relate to function but also
provide important insight into the transmission and
sources for acquisition of transposons in clinical E.
faecium strains. The location of the van locus on mobile
elements permits spread via horizontal gene transfer as
well as clonal spread. It is important to establish the
exact mechanisms that lead to the acquisition of anti-
biotic resistance, particularly in hospital-adapted strains,
in order to understand the emergence of VRE and to pre-
vent the spread of resistance to VSE or other bacterial spe-
cies. While both Aus0004 and Aus0085 possess transposon
insertion sites that differ from those previously described
as preferred integration sites [47] (Figure 3), further ana-
lysis may reveal common insertion sites that distinguish
the ST17 and ST203 isolates. Identifying these sources
for transposon and vancomycin-resistance acquisition
may potentially lead to diagnostic differences that can
be exploited prevent VRE infection through the elimination
of the sources.
We have also characterized some of the phenotypic
differences between ST17 and ST203 E. faecium. The
isolates we selected to study came from a previously
described ST203 outbreak, which reported the displace-
ment of resident ST17 E. faecium VRE with ST203.
Given the significant number of additional metabolic
genes in Aus0085, experiments assessing the rate of
Figure 6 24-hour biofilm assays, performed in TSB supplemented with 1% glucose. OD570nm readings were measured for each strain to
determine the amount of biofilm formed. Isolates Aus0006, Aus0019 and Aus0094 exhibited significantly enhanced biofilm production compared
to the other isolates (p < 0.001).
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itional genes yielded improved growth. Comparisons of
13 ST17 and 15 ST203 isolates highlighted significantly
increased growth rates and competitive fitness for ST203
that may be factors contributing to the emergence of
this clone in our hospital. Notably, Aus0004 possessed a
prolonged lag phase compared to the other strains, and
the delay in reaching exponential phase is likely to be
due to its abnormal GC skew pattern arising from
imbalanced replichores [22].Figure 7 Galleria mellonella survival. Percentage of survival of larvae ino
at day 3 and day 8. Both clonal groups possessed virulent strains that resul
not kill all the larvae by day 8.ST17 and ST203 comparisons of virulence using G.
mellonella larvae demonstrated a range of virulence
phenotypes in larvae inoculated with isolates from either
clonal group. A potentially interesting difference was
observed with the ST203 strains isolated from 2009
onwards, killing G. mellonella faster than earlier isolates
of either sequence type. Genome comparisons however
revealed few differences between the known virulence
factors in Aus0004 and Aus0085. Both genomes contained
genes encoding virulence factors such as hemolysin andculated with a (A) ST17 E. faecium strain or (B) ST203 E. faecium strain
ted in the death of all larvae by day 3 and avirulent strains that did
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http://www.biomedcentral.com/1471-2164/14/595enterococcal surface protein (esp). Esp appears very
important for the ability of E. faecium to colonize the host
[30,49-51]. Variations in its length, such as observed here,
may alter function and explain the difference in G.
mellonella virulence we observed between Aus0004 and
Aus0085. Variation in Esp expression [30], as well as the
potential of using the apparent variability of esp to
discriminate between different ST17 and ST203 strains,
were not explored here and remain to be investigated. We
currently are trying to understand global differences in
gene expression between Aus0004 and Aus0085 using
RNAseq and the completed reference genomes.
Conclusions
The extent of variability between the three E. faecium
genomes compared here highlights the significant roles
played by mobile genetic elements in shaping the evolution
of this species. The additional 502 kb in ST203 Aus0085
with genes that likely confer additional metabolic functions
and antimicrobial resistances, help explain the emergence
of this clone. These observations coincide with the, on
average, faster growth and increased competitiveness of
ST203 compared to ST17. While this study has provided
several insights into differences that distinguish the ST17
from ST203 E. faecium strains, differences in the expres-
sion of particular genes also require investigation. In this
respect, the completed Aus0085 genome represents an
important resource as a reference for read-mapping appli-
cations such asRNAseq for exploring the E. faecium tran-
scriptome, or for high-resolution molecular epidemiology
to better understand the factors behind the emergence of
this opportunistic nosocomial pathogen.
Methods
Bacterial sequences and strains
The strains used in this study were selected from isolates
previously reported [14] to represent the ST17 and
ST203 E. faecium strains collected over a 12-year period
from bacteraemia patients at the Austin Hospital
(Table 2). Bacterial cultures were prepared in brain heart
infusion (BHI) broth unless otherwise stated.
Antimicrobial susceptibility testing
Antimicrobial susceptibility tests determining the MICs
against vancomycin and streptomycin were performed for
isolates Aus0004 and Aus0085 by Macromethod Etest.
Genome sequencing and assembly
Genomic DNA was sequenced on a 454 GS FLX instru-
ment using a 3 kbp mate-pair library yielding 100 K reads
of average length 402-bp (Roche Diagnostics, Basel,
Switzerland), and on an Illumina GAIIx using a paired-end
library yielding 12M reads of length 36-bp. The 454 reads
were de novo assembled using Newbler (v2.6). The Illuminareads were used to correct errors in the Newbler scaffolds.
Finishing was managed with Gap4, using combinations of
PCR, primer walking and sequencing of selected
clones from a 50-kb insert-size E. coli bacterial artificial
chromosome (BAC) E. faecium Aus0085 clone library.
Correct assembly was validated by reference to a previously
described NcoI Optical Map (Opgen) [14].
Genome analysis
Genome annotation of E. faecium Aus0085 was performed
using the in-house tools Prokka and Wasabi (http://www.
bioinformatics.net.au). Comparison of whole chromosome
DNA sequences for E. faecium isolates Aus0004, Aus0085
and TX16 were compared using the Artemis Comparison
Tool (ACT), Mauve (v2.3.1) and BLAST Ring Image
Generator (BRIG) [52-55]. Mobile genetic elements such
as insertion sequence elements (ISEs) and phage regions
were identified using the genome annotation, ISfinder and
Phast [56,57]. CRISPRfinder was used to screen for the
presence of CRISPR elements [58].
Multi-isolate comparative genomics
Through a larger, separate study examining VRE trans-
mission, 2× 100 bp paired-end Illumina sequence reads
were available for the 26 isolates listed in Table 2
(Howden et al., submitted). These reads were aligned
separately to the completed Aus0085 genome using
SHRiMP 2.0 [59]. Those positions in Aus0085 that were
covered by at least one read from every genome defined
a core genome. Read-mapping outputs were visualized
in Artemis. SNPs were identified using Nesoni v0.35, a
Python utility that uses the sequence reads for each
genome aligned to the core genome to construct a
tally of putative differences at each nucleotide position
(including substitutions, insertions, and deletions). This
tally was then used in a Bayesian model to decide whether
a base or deletion could be called for the position,
and if so, whether it differed from the reference sequence
(www.bioinformatics.net.au). Phylogenetic analyses were
performed using a distance method, based on pairwise
nucleotide sequence alignments for the core genome among
all isolates. Split decomposition and Neighbour-joining
analysis was employed using uncorrected p distances as
implemented in SplitsTree4 [60]. The reads from these
26 isolates were also subject to de novo assembly
using Velvet (v1.2.04) [61] and annotation with Prokka.
The resulting protein-coding DNA sequences (CDS) were
used as for ortholog clustering analysis. Ortholog cluster-
ing was performed using derived amino acid sequences for
each CDS in CD-HIT v4.6 (default parameters) [62], with
the clustering requirement that specific sets have represen-
tatives in all their genomes related to that set. The sets
were defined as ‘core genes present in all ST17 and ST203’,
‘ST203-specific genes’ and ‘ST17-specific genes’).
Lam et al. BMC Genomics 2013, 14:595 Page 13 of 15
http://www.biomedcentral.com/1471-2164/14/595Nucleotide accession numbers
The complete genome sequence and annotation for
E. faecium Aus0085 has been deposited in GenBank
under Bioproject ID PRJNA193299 and accession
numbers CP006620-CP006626.
Growth curves
Growth curves were generated for the E. faecium strains
by adding a 100 μl 1:100 dilution of overnight culture,
prepared in BHI broth, to individual wells in a 96-well
flat-bottom plate and incubated over a 24-hour period at
37°C. Starting from time point 0, OD600nm measurements
were made at hourly intervals over a 24-hour period. The
generation and doubling times were determined for each
of the strains during a 2 hour period during exponential
phase of growth according to the following formulas:
Generation time (GT), in mins = (logNt – logN0) ÷ log2,
Nt =OD value at end of exponential period, N0 =OD
value at beginning of exponential period, Doubling time
(DT), in mins = (Δt ÷ GT) × 60, Δt = 2 hours Growth
curve experiments were repeated three times.
Competition growth assays
For each experiment, a 1:200 dilution of an overnight
culture from ST17 isolates Aus0004 or Aus0021 (low
level resistance to gentamicin, MIC = 6 mg/L) and ST203
isolates Aus0085 or Aus0090 (high level resistance to
gentamicin, MIC > 1024 mg/L) were separately added to
50 mL BHI broth and incubated over a 24-hour period at
37°C. Starting from time point 0, 1 mL samples were
taken at hourly intervals for OD600nm measurements
until a constant reading was attained and again at time
point 24 h. The ratio of ST17 colonies to ST203 colonies
was determined by plating 100 μl of the serial dilutions
prepared from the samples on BHI agar and BHI agar
with 100 mg/L gentamicin. To analyse the relative fitness
of the ST203 strain compared to the ST17 strain when
grown together under experimental conditions, the follow-
ing formula was used to calculate the Relative Competitive
Fitness Index (RCFI): RCFI = [ln(number of ST203 colonies
at 24 hours ÷ number of ST203 colonies at 0 hours)] ÷ [ln
(number of ST17 colonies at 24 hours ÷ number of ST17
colonies at 0 hours)] [63] Each competition growth assay
experiment was repeated at least three times. Statistical
significance of the differences between the sample
means compared to a threshold value of 1.0 were assessed
using one sample t-test.
Biofilm assays
Overnight cultures were prepared using tryptic soy broth
(TSB) supplemented with 1% glucose. 96-well polystyrene
flat-bottom microtitre plates were coated with 200 μl 1:200
diluted E. faecium overnight culture in TSB with 1%
glucose. Following a 24-hour stationary incubationperiod at 37°C, the plates were washed with phosphate
buffered saline (PBS), stained with 125 μl 0.1% w/v crystal
violet, and left at room temperature for 10 minutes. The
plates were then washed with PBS and left to dry for a
further 10 minutes before the addition of 125 μl 80:20
ethanol acetone. Absorbance measurements at OD570nm
were determined for each well. Experiments were repeated
an additional two times.Galleria mellonella time kill assays
The virulence of the E. faecium strains was assessed
using a previously described Galleria mellonella
(Greater Wax Moth) invertebrate infection model that
has been utilized in several studies as an invertebrate
model to study the virulence of pathogenic organisms
including Staphylococcus aureus and Enterococcus faecalis
[64-66]. In brief, G. mellonella larvae in the final instar
were inoculated in groups of 16 with a particular E.
faecium isolate. Bacterial suspensions for each isolate were
prepared by washing cells with PBS that were harvested
from overnight cultures. Ten microliters of the bacterial sus-
pension, comprised of approximately 0.5–1.0 × 109 CFU/mL,
was injected into the hamocoel via the first right pro-
leg of each larva. The bacterial suspensions from
which the inoculums were taken were plated onto
BHI agar in duplicates to check the starting cell concen-
tration. Following injection, the larvae were incubated at
37°C and the number of dead larvae were recorded daily.
The number of bacteria in the larvae at time of death
was quantified. This quantification was achieved by
plating serial dilutions of the hemolymph onto BHI
agar. The assays were repeated in biological triplicates
(three different bacterial suspensions), and control
groups with larvae inoculated with PBS were included.
The percentage of survival at days 3 and 8 was calculated
for each strain.Ethics statement
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